5-(dimethoxymethyl)-2′-deoxyuridine:: A novel gem diether nucleoside with anti-orthopoxvirus activity

被引:28
作者
Fan, Xuesen
Zhang, Xinying
Zhou, Longhu
Keith, Kathy A.
Kern, Earl R.
Torrence, Paul F. [1 ]
机构
[1] No Arizona Univ, Dept Chem & Biochem, Flagstaff, AZ 86011 USA
[2] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35233 USA
关键词
D O I
10.1021/jm0601710
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To provide potential new leads for the treatment of orthopoxvirus infections, the 5-position of the pyrimidine nucleosides have been modified with a gem diether moiety to yield the following new nucleosides: 5-(dimethoxymethyl)-2-deoxyuridine (2b), 5-(diethoxymethyl)-2-deoxyuridine (3b), 5-formyl-2-deoxyuridine ethylene acetal (4b), and 5formyl-2-deoxyuridine propylene acetal (5b). These were evaluated in human foreskin fibroblast cells challenged with the vaccinia virus or cowpox virus. Of the four gem diether nucleosides, only the dimethyl gem diether congener showed significant antiviral activity against both viruses. This antiviral activity did not appear to be related to the decomposition to the 5-formyl-2-deoxyuridine, which was itself devoid of anti-orthopoxvirus activity in these assays. Moreover, at the pH of the in vitro assays, 2b was very stable with a decomposition (to aldehyde) half-life of > 15 d. The anti-orthopoxvirus activity of pyrimidine may be favored by the introduction of hydrophilic moieties to the 5- position side chain.
引用
收藏
页码:3377 / 3382
页数:6
相关论文
共 73 条
  • [1] Harnessing new science is vital for biodefense and global health
    Alberts, B
    Fineberg, HV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) : 11177 - 11177
  • [2] Increased antiviral activity of 1-O-hexadecyloxypropyl-[ 2-14C] cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism
    Aldern, KA
    Ciesla, SL
    Winegarden, KL
    Hostetler, KY
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 678 - 681
  • [3] Smallpox: a disease and a weapon
    Alibek, K
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2004, 8 : S3 - S8
  • [4] Arita I, 2004, JPN J INFECT DIS, V57, P1
  • [5] Botulinum toxin as a biological weapon - Medical and public health management
    Arnon, SS
    Schechter, R
    Inglesby, TV
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Fine, AD
    Hauer, J
    Layton, M
    Lillibridge, S
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Swerdlow, DL
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08): : 1059 - 1070
  • [6] Artenstein Andrew W, 2003, Med Health R I, V86, P201
  • [7] Globalizing biosecurity
    Atlas, RM
    Reppy, J
    [J]. BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2005, 3 (01) : 51 - 60
  • [8] Biological agents with potential for misuse: a historical perspective and defensive measures
    Bhalla, DK
    Warheit, DB
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 199 (01) : 71 - 84
  • [9] Hemorrhagic fever viruses as biological weapons - Medical and public health management
    Borio, L
    Inglesby, T
    Peters, CJ
    Schmaljohn, AL
    Hughes, JM
    Jahrling, PB
    Ksiazek, T
    Johnson, KM
    Meyerhoff, A
    O'Toole, T
    Ascher, MS
    Bartlett, J
    Breman, JG
    Eitzen, EM
    Hamburg, M
    Hauer, J
    Henderson, A
    Johnson, RT
    Kwik, G
    Layton, M
    Lillibridge, S
    Nabel, GJ
    Osterholm, MT
    Perl, TM
    Russell, P
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2391 - 2405
  • [10] Death due to bioterrorism-related inhalational anthrax - Report of 2 patients
    Borio, L
    Frank, D
    Mani, V
    Chiriboga, C
    Pollanen, M
    Ripple, M
    Ali, S
    DiAngelo, C
    Lee, J
    Arden, J
    Titus, J
    Fowler, D
    O'Toole, T
    Masur, H
    Bartlett, J
    Inglesby, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20): : 2554 - 2559